{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:45:38Z","timestamp":1761864338448,"version":"3.37.3"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"9","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII)-Subdirecci\u00f3n General de Evaluaci\u00f3n","doi-asserted-by":"publisher","award":["PI19\/01084"],"award-info":[{"award-number":["PI19\/01084"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO\/2018\/135","ACCI-2018-22","ACCI-2019- 22"],"award-info":[{"award-number":["PROMETEO\/2018\/135","ACCI-2018-22","ACCI-2019- 22"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPPS"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The approval of istradefylline, an adenosine 2A receptor (A2AR) antagonist, as an addon\ntreatment in adult patients with Parkinson\u2019s disease by the Food and Drug Administration (FDA)\nand European Medicines Agency (EMA), is the latest proof of the importance of the adenosinergic\nsystem in the nervous system. Adenosine is an endogenous purine nucleoside with a role as a modulator\nof both neurotransmission and the inflammatory response. As such, the expression pattern of\nthe 4 adenosine receptors (A1R, A2AR, A2BR and A3R) and the extracellular adenosine levels\nhave attracted great interest in the pathogenesis and possible treatment of rare neurodegenerative\ndiseases with motor symptoms. These include Huntington\u2019s Disease (HD), Amyotrophic Lateral\nSclerosis (ALS), Multiple Sclerosis (MS), Restless Legs Syndrome (RLS) and Machado-Joseph\nDisease (MJD, also known as spinocerebellar ataxia type 3, SCA3). In this review, we shall focus\non the role of the different adenosine receptor subtypes in the development and possible treatment\nof the aforementioned rare neurodegenerative diseases with motor symptoms using the currently\navailable data. The last section discusses the possibility of a role for the adenosine receptors in the\ntreatment of other rare diseases based on the available molecular pathology knowledge.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389203722666210910110126","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T09:25:45Z","timestamp":1631525145000},"page":"675-694","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of Adenosine Receptors in Rare Neurodegenerative Diseases with\nMotor Symptoms"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9142-6071","authenticated-orcid":true,"given":"Vicent","family":"Beltran-Beltran","sequence":"first","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia-INCLIVA, Valencia 46010,Spain | Biomedical Research Institute INCLIVA, 46010 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3087-5057","authenticated-orcid":true,"given":"Noelia","family":"Benet\u00f3","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia-INCLIVA, Valencia 46010,Spain | Biomedical Research Institute INCLIVA, 46010 Valencia, Spain; | CIBER de Enfermedades Raras (CIBERER),\nValencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6605-9708","authenticated-orcid":true,"given":"Tamara","family":"Lape\u00f1a-Luz\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia-INCLIVA, Valencia 46010,Spain | Biomedical Research Institute INCLIVA, 46010 Valencia, Spain; | CIBER de Enfermedades Raras (CIBERER),\nValencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5290-2266","authenticated-orcid":true,"given":"Laura R.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia-INCLIVA, Valencia 46010,Spain | Biomedical Research Institute INCLIVA, 46010 Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3715-1980","authenticated-orcid":true,"given":"Federico V.","family":"Pallard\u00f3","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia-INCLIVA, Valencia 46010,Spain | Biomedical Research Institute INCLIVA, 46010 Valencia, Spain | CIBER de Enfermedades Raras (CIBERER), Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-6334","authenticated-orcid":true,"given":"Pilar","family":"Gonzalez-Cabo","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia-INCLIVA, Valencia 46010,Spain | Biomedical Research Institute INCLIVA, 46010 Valencia, Spain | CIBER de Enfermedades Raras (CIBERER),\nValencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Protein &amp; Peptide Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/196355","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/196355\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/196355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T10:14:20Z","timestamp":1645179260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/196355\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389203722666210910110126","relation":{},"ISSN":["1389-2037"],"issn-type":[{"type":"print","value":"1389-2037"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}